Fig. 1From: Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophreniaDesign of the lurasidone open-label core and extension switch studies.* 144 of the 235 (61Â %) patients included in the core 6-week study of HRQoL were includedBack to article page